(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -0.32% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Neogen's revenue in 2025 is $886,886,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2026 to be $182,480,867,156, with the lowest NEOG revenue forecast at $173,556,412,586, and the highest NEOG revenue forecast at $189,467,017,982. On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $185,768,595,367, with the lowest NEOG revenue forecast at $173,875,841,566, and the highest NEOG revenue forecast at $193,734,762,997.
In 2028, NEOG is forecast to generate $191,490,068,190 in revenue, with the lowest revenue forecast at $182,563,440,634 and the highest revenue forecast at $198,639,192,985.